Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
Nifty Pharma index hits 52-week high; Ipca, Aurobindo rally up to 4%
In the past one month, the Nifty Pharma index has rallied 4.5 per cent, as against 7.8 per cent decline in the benchmark Nifty 50.

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.

Sensex Today | Stock Market Live: Sensex jumps 230 pts, Nifty above 23,900; KPIT Tech slips 10% on softer Q1 outlook
Sensex Today | Stock Market LIVE Updates: Indian benchmark indices extended the opening gains and trading around 23950. Except metal, all other sectoral indices are trading in the green with auto, FMCG, media up 1-1.5%. Nifty Midcap index trade flat and Smallcap index up 0.4%. Titan Company, M&M, Eternal, Sun Pharma, Bajaj Auto were among major gainers on the Nifty, while losers were Bajaj Finserv, HDFC Life, Coal India, Tech Mahindra, Interglobe Aviation.

LIVE: Nifty fails to hold 24,000; metals outperform | Closing Bell
Markets ended lower, snapping a two-day winning streak, with benchmark indices pressured by weakness in financials and select heavyweight stocks. The Sensex declined over 300 points, while the Nifty failed to hold above the crucial 24,000 mark. Market breadth remained weak, with decliners outnumbering advancers by nearly two-to-one on the BSE, reflecting broad-based selling. Investor caution was also evident as the India VIX climbed around 5%, indicating a pickup in volatility expectations. On the sectoral front, pharma and metal stocks bucked the trend, with the Metal index snapping a three-session losing streak. Banking stocks remained under pressure, dragging the Bank Nifty below the 58,000 mark. Among the Nifty 50 gainers, Dr Reddy's, Max Healthcare and Trent led the advances, while Kotak Mahindra Bank, Mahindra & Mahindra and IndiGo were among the biggest losers of the session.

Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list
Pharma stocks led the gains on benchmark Nifty 50 and the BSE Midcap index on Tuesday. Dr Reddy's, Sun Pharma and Cipla were the top 3 Nifty gainers, amid news reports that the US FDA has asked Indian firms to help address a shortage of ifosfamide injection.

SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.